Rajaratnam Brother Returns To U.S. To Face Insider-Trading Charges

Mar 25 2013 | 9:18am ET

Galleon Group founder Raj Rajaratnam's younger brother has surrendered to authorities and will appear in court to face insider-trading charges today.

Rajarengan Rajaratnam turned himself in to the Federal Bureau of Investigation in Brazil and was accompanied to New York by agents. He was arrested upon his arrival at John F. Kennedy International Airport yesterday morning.

Rajaratnam had been living and working in Brazil for about a year, his lawyer said, and he returned voluntarily, sparing prosecutors an extradition battle.

Rajaratnam was indicted last week on securities fraud and conspiracy charges, some two years after his brother was convicted of similar charges. The elder Rajaratnam is currently serving an 11-year prison sentence.

The younger Rajaratnam, known as Rengan, is accused of illegally trading two technology stocks while working at Galleon. His brother was convicted of insider-trading of those stocks and others. The Securities and Exchange Commission has also sued Rengan, accusing him of illicit trading in a number of other stocks.

Rengan's lawyer, David Tobin, said his client is innocent.

"Mr. Rajaratnam denies the charges and looks forward to clearing his name," Tobin said. "We are confident that Mr. Rajaratnam will be vindicated upon careful considering of all the evidence."


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The healthcare sector went on a tear beginning in 2011, thanks in large part to the passage of the Affordable Care Act and its impending implementat